FDA reconsider rare lymphoma treatment after outlining a path for resubmission of tabelecleucel's biologics license application.

The company will submit an updated dataset with additional patients, longer follow up, and supportive data from the ALLELE study to support its BLA.

Broader implementation would require substantial investment, but long-term dividends of liquid biopsy analysis in the region ...

Scientists have developed antibodies that block a common virus linked to cancer and autoimmune diseases from infecting immune ...

Absence of typical risk factors can coexist with diagnosis, reinforcing the limited predictive value of current risk ...

Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of ...

Scientists have taken a major step toward stopping Epstein-Barr virus (EBV), an extremely common infection linked to cancer and chronic disease. By using mice engineered with human antibody genes, ...